Skip to main content
Erschienen in: Journal of Clinical Immunology 5/2006

01.09.2006

Ex-Vivo Analysis of CD8+ T Cells Infiltrating Colorectal Tumors Identifies a Major Effector-Memory Subset with Low Perforin Content

verfasst von: SHENG-WEI YE, YU WANG, DANILA VALMORI, MAHA AYYOUB, YAN HAN, XIAO-LAN XU, AI-LIAN ZHAO, LI QU, SACHA GNJATIC, GERD RITTER, LLOYD J. OLD, JIN GU

Erschienen in: Journal of Clinical Immunology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Previous studies have indicated that the infiltration of CD8+ T cells in colorectal cancer is an independent predictor of increased survival but clinical observations have suggested that the cytotoxic function of CD8+ T cells infiltrating colorectal cancer may often be limited. In this study, we have assessed the phenotype of colorectal cancer CD8+ tumor-infiltrating lymphocytes (TILs) isolated ex vivo from tumor tissue, and assessed the perforin content of TIL with respect to their location using immunohistochemistry. We found that CD8+ T cells TILs isolated from colorectal cancer are mainly composed of antigen-experienced cells of effector memory type (TEM, CD45RA-CCR7−, and CD27+/CD28− or CD27−/CD28−), and contain only minor proportions of terminally differentiated CD8+ T cells (TEMRA, CD45RA+CCR7−). The perforin content of these TILs, however, is significantly lower than that of antigen-experienced T cells in PBMCs due to the much lower levels of perforin found in the CD27-CD28− subset in TILs compared with CD8+ T cells of similar phenotype in PBMCs.
Literatur
1.
Zurück zum Zitat Saeterdal I, Bjorheim J, Lislerud K, et al.: Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 98:13255–13260, 2001PubMedCrossRef Saeterdal I, Bjorheim J, Lislerud K, et al.: Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 98:13255–13260, 2001PubMedCrossRef
2.
Zurück zum Zitat Linnebacher M, Gebert J, Rudy W, et al.: Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens. Int J Cancer 93:6–11, 2001PubMedCrossRef Linnebacher M, Gebert J, Rudy W, et al.: Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens. Int J Cancer 93:6–11, 2001PubMedCrossRef
3.
Zurück zum Zitat Ito M, Shichijo S, Miyagi Y, et al.: Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes. Int J Cancer 88:633–639, 2000PubMedCrossRef Ito M, Shichijo S, Miyagi Y, et al.: Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes. Int J Cancer 88:633–639, 2000PubMedCrossRef
4.
Zurück zum Zitat Nagorsen D, Keilholz U, Rivoltini L, et al.: Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res 60:4850–4854, 2000PubMed Nagorsen D, Keilholz U, Rivoltini L, et al.: Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res 60:4850–4854, 2000PubMed
5.
Zurück zum Zitat Scanlan MJ, Welt S, Gordon CM, et al.: Cancer-related serological recognition of human colon cancer: Identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62:4041–4047, 2002PubMed Scanlan MJ, Welt S, Gordon CM, et al.: Cancer-related serological recognition of human colon cancer: Identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62:4041–4047, 2002PubMed
6.
Zurück zum Zitat Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J: Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Clin Cancer Res 11:1809–1814, 2005PubMedCrossRef Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J: Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Clin Cancer Res 11:1809–1814, 2005PubMedCrossRef
7.
Zurück zum Zitat Naito Y, Saito K, Shiiba K, et al.: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494, 1998PubMed Naito Y, Saito K, Shiiba K, et al.: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494, 1998PubMed
8.
Zurück zum Zitat Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712, 1999PubMedCrossRef Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712, 1999PubMedCrossRef
9.
Zurück zum Zitat Appay V, Dunbar PR, Callan M, et al.: Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379–385, 2002PubMedCrossRef Appay V, Dunbar PR, Callan M, et al.: Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379–385, 2002PubMedCrossRef
10.
Zurück zum Zitat Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD: Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol 3:991–998, 2002PubMedCrossRef Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD: Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol 3:991–998, 2002PubMedCrossRef
11.
Zurück zum Zitat Mortarini R, Piris A, Maurichi A, et al.: Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res 63:2535–2545, 2003PubMed Mortarini R, Piris A, Maurichi A, et al.: Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res 63:2535–2545, 2003PubMed
12.
Zurück zum Zitat Zippelius A, Batard P, Rubio-Godoy V, et al.: Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance. Cancer Res 64:2865–2873, 2004PubMedCrossRef Zippelius A, Batard P, Rubio-Godoy V, et al.: Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance. Cancer Res 64:2865–2873, 2004PubMedCrossRef
14.
Zurück zum Zitat Hishii M, Kurnick JT, Ramirez-Montagut T, Pandolfi F: Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes. Clin Exp Immunol 116:388–394, 1999PubMedCrossRef Hishii M, Kurnick JT, Ramirez-Montagut T, Pandolfi F: Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes. Clin Exp Immunol 116:388–394, 1999PubMedCrossRef
15.
Zurück zum Zitat Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA, et al.: Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755–760, 2000PubMedCrossRef Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA, et al.: Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755–760, 2000PubMedCrossRef
16.
Zurück zum Zitat Smyth MJ, Street SE, Trapani JA: Cutting edge: Granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol 171:515–518, 2003PubMed Smyth MJ, Street SE, Trapani JA: Cutting edge: Granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol 171:515–518, 2003PubMed
17.
Zurück zum Zitat Gupta S: Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev 205:114–129, 2005PubMedCrossRef Gupta S: Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev 205:114–129, 2005PubMedCrossRef
18.
Zurück zum Zitat Watanabe N, Hizuta A, Tanaka N, Orita K: Localization of T cell receptor (TCR)-γδ+ T cells into human colorectal cancer: Flow cytometric analysis of TCR-γδ expression in tumor-infiltrating lymphocytes. Clin Exp Immunol 102:161–173, 1995 Watanabe N, Hizuta A, Tanaka N, Orita K: Localization of T cell receptor (TCR)-γδ+ T cells into human colorectal cancer: Flow cytometric analysis of TCR-γδ expression in tumor-infiltrating lymphocytes. Clin Exp Immunol 102:161–173, 1995
19.
Zurück zum Zitat Tomiyama H, Matsuda T, Takiguchi M: Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J Immunol 168:5538–5550, 2002PubMed Tomiyama H, Matsuda T, Takiguchi M: Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J Immunol 168:5538–5550, 2002PubMed
20.
Zurück zum Zitat Tomiyama H, Takata H, Matsuda T, Takiguchi M: Phenotypic classification of human CD8+ T cells reflecting their function: Inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 34:999–1010, 2004PubMedCrossRef Tomiyama H, Takata H, Matsuda T, Takiguchi M: Phenotypic classification of human CD8+ T cells reflecting their function: Inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 34:999–1010, 2004PubMedCrossRef
21.
Zurück zum Zitat Rubio V, Stuge TB, Singh N, et al. Ex vivo identification and analysis of tumor-cytolytic T cells. Nat Med 9(11):1377–1382, 2003PubMedCrossRef Rubio V, Stuge TB, Singh N, et al. Ex vivo identification and analysis of tumor-cytolytic T cells. Nat Med 9(11):1377–1382, 2003PubMedCrossRef
22.
Zurück zum Zitat Guidoboni M, Gafa R, Viel A, et al.: Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 159:297–304, 2001PubMed Guidoboni M, Gafa R, Viel A, et al.: Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 159:297–304, 2001PubMed
23.
Zurück zum Zitat Neilsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesggaard F: Independent prognotic value of eosiniphil and mast cell infiltration in colorectal cancer. J Pathol 189:487–495, 1999CrossRef Neilsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesggaard F: Independent prognotic value of eosiniphil and mast cell infiltration in colorectal cancer. J Pathol 189:487–495, 1999CrossRef
24.
Zurück zum Zitat Yannelli JR, Hyatt C, McConnell S, et al.: Growth of tumor-infiltrating lymphocytes from human solid cancers: Summary of a 5-year experience. Int J Cancer 65:413–421, 1996PubMedCrossRef Yannelli JR, Hyatt C, McConnell S, et al.: Growth of tumor-infiltrating lymphocytes from human solid cancers: Summary of a 5-year experience. Int J Cancer 65:413–421, 1996PubMedCrossRef
25.
Zurück zum Zitat Hawkins MJ, Atkins MB, Dutcher JP, et al.: A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma. J Immunother 15:74–78, 1994CrossRef Hawkins MJ, Atkins MB, Dutcher JP, et al.: A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma. J Immunother 15:74–78, 1994CrossRef
26.
Zurück zum Zitat Fabbri M, Ridolfi R, Maltoni R, et al.: Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma. Tumori 86:46–52, 2000PubMed Fabbri M, Ridolfi R, Maltoni R, et al.: Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma. Tumori 86:46–52, 2000PubMed
27.
Zurück zum Zitat Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S: Tumor as elusive targets of T-cell-based active immunotherapy. Trends Immunol 24(6):334–341, 2003CrossRef Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S: Tumor as elusive targets of T-cell-based active immunotherapy. Trends Immunol 24(6):334–341, 2003CrossRef
28.
Zurück zum Zitat Diederichsen ACP, Zeuthen J, Christensen PB, Kristensen T: Characterisation of tumor infiltrating lymphocytes and correlation with immunological surface molecules in colorectal caner. Eur J Cancer 35(5):721–726, 1999PubMedCrossRef Diederichsen ACP, Zeuthen J, Christensen PB, Kristensen T: Characterisation of tumor infiltrating lymphocytes and correlation with immunological surface molecules in colorectal caner. Eur J Cancer 35(5):721–726, 1999PubMedCrossRef
29.
Zurück zum Zitat Costantinia A, Mancinia S, Giuliodoroa S, Butinia L, Regnerya CM, Silvestrib G, Montronia M: Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods 278:145–155, 2003CrossRef Costantinia A, Mancinia S, Giuliodoroa S, Butinia L, Regnerya CM, Silvestrib G, Montronia M: Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods 278:145–155, 2003CrossRef
30.
Zurück zum Zitat Champagne P, Ogg FS, King AS, et al.: Skewed maturation of memory HIV-specific CD8 T lymphocyte. Nature 410:106–111, 2001PubMedCrossRef Champagne P, Ogg FS, King AS, et al.: Skewed maturation of memory HIV-specific CD8 T lymphocyte. Nature 410:106–111, 2001PubMedCrossRef
31.
Zurück zum Zitat Unitt E, Rushbrook SM, Marshall A, et al.: Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells. Hepatology 41:722–730, 2005PubMedCrossRef Unitt E, Rushbrook SM, Marshall A, et al.: Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells. Hepatology 41:722–730, 2005PubMedCrossRef
32.
Zurück zum Zitat Spiotto MT, Rowley DA, Schreiber H: Bystander elimination of antigen loss variants in established tumors. Nat Med 10:294–298, 2004PubMedCrossRef Spiotto MT, Rowley DA, Schreiber H: Bystander elimination of antigen loss variants in established tumors. Nat Med 10:294–298, 2004PubMedCrossRef
33.
Zurück zum Zitat Spiotto MT, Schreiber H: Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens crosspresented by stromal cells. Cancer Immun 5:8–15, 2005PubMed Spiotto MT, Schreiber H: Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens crosspresented by stromal cells. Cancer Immun 5:8–15, 2005PubMed
Metadaten
Titel
Ex-Vivo Analysis of CD8+ T Cells Infiltrating Colorectal Tumors Identifies a Major Effector-Memory Subset with Low Perforin Content
verfasst von
SHENG-WEI YE
YU WANG
DANILA VALMORI
MAHA AYYOUB
YAN HAN
XIAO-LAN XU
AI-LIAN ZHAO
LI QU
SACHA GNJATIC
GERD RITTER
LLOYD J. OLD
JIN GU
Publikationsdatum
01.09.2006
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 5/2006
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9040-4

Weitere Artikel der Ausgabe 5/2006

Journal of Clinical Immunology 5/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.